Advanced CT-based cardiac diagnostics software for assessing the hemodynamic significance of coronary lesions.
AI-powered ECG monitoring solutions for clinical trials focused on cardiac safety, compliance, and data accuracy.
Medical technology R&D focused on AI, cardiovascular disease diagnosis, and next-generation diagnostic solutions.
These principles play a crucial part in the company’s daily operations. Medicalgorithmics S.A. adhered to the Good Practices of Companies Listed on the Warsaw Stock Exchange (WSE) 2016 and, as of July 1, 2021, follows the Good Practices of Companies Listed on the WSE 2021. Declarations regarding the application of Good Practices have been published below.
About us
Our History
Management Team
Partners
Work with us
Job offers
Recommend an employee
Application form